Brief: Onxeo Receives EPO Intent-To-Grant Notice For New Patent

Valerio Therapeutics SA

14/10/2019 17:22

Oct 14 (Reuters) - ONXEO SA  C4X.PA :
    * ONXEO RECEIVES EPO INTENT-TO-GRANT NOTICE FOR NEW PATENT
STRENGTHENING EUROPEAN PROTECTION OF COMPOUNDS SOURCED FROM ITS
PLATON™ PLATFORM
    * NEW PATENT PROTECTS IN PARTICULAR ASIDNA™ AND ITS RELATED
COMPOUNDS FOR THEIR USE IN TREATMENT OF CANCER, ALONE OR IN
COMBINATION WITH OTHER TUMOR DNA-DAMAGING AGENTS
    * PATENT WILL PROVIDE A TERM OF PROTECTION VALID UNTIL
MID-2031,
WHICH COULD BE FURTHER EXTENDED UNTIL 2036

Source text for Eikon:  ID:nBw49lMRVa 
Further company coverage:  C4X.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48587785110;))